title: Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer.
authors.forename: C
authors.initials: C
authors.lastname: Mao
authors.forename: R-Y
authors.initials: RY
authors.lastname: Liao
authors.forename: Q
authors.initials: Q
authors.lastname: Chen
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D015179:Colorectal Neoplasms / Q000276:immunology / Q000556:secondary* / Q000628:therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D015201:Meta-Analysis as Topic; D051059:PTEN Phosphohydrolase / Q000172:deficiency*; D011379:Prognosis
chemical_list: D000911:Antibodies, Monoclonal; C512478:EGFR protein, human; D066246:ErbB Receptors; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human